Andrea Jackson

Andrea Jackson is a Partner at Northpond Ventures where she leads the investment team. She joined Northpond in 2020 after 12 years working in operating and finance roles within public and private life sciences companies. She serves as a board director at multiple technology and life sciences companies including DNAnexus, Saama, VieCure, Elephas, Emulate, OriBiotech, Refeyn, and Vizgen. Previously, Andrea served on the boards of Current Health (acquired by Best Buy), DeepLens (acquired by Paradigm), and NanoView Biosciences (acquired by Unchained Labs). Prior to her operating roles, Andrea worked on JPMorgan’s Healthcare Investment Banking team. Andrea received an MBA from the Kellogg School of Management at Northwestern University and a B.A. with honors from Washington University in St. Louis.